Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peficitinib Extension Study in Rheumatoid Arthritis
NCT01638013Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2012
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of peficitinib in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Started Jun 2012; status: completed.
02
Drugs
peficitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01638013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638013.